Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Times Interest Earned (2016 - 2024)

Lifecore Biomedical, Inc. \De\ has reported Times Interest Earned over the past 15 years, most recently at -$0.42 for Q4 2024.

  • Quarterly results put Times Interest Earned at -$0.42 for Q4 2024, up 7.39% from a year ago — trailing twelve months through May 2025 was -$3.08 (down 660.78% YoY), and the annual figure for FY2024 was -$0.6, up 99.03%.
  • Times Interest Earned for Q4 2024 was -$0.42 at Lifecore Biomedical, Inc. \De\, up from -$11.78 in the prior quarter.
  • Over the last five years, Times Interest Earned for LFCR hit a ceiling of $1.33 in Q4 2021 and a floor of -$11.78 in Q3 2024.
  • Median Times Interest Earned over the past 5 years was -$0.57 (2021), compared with a mean of -$1.75.
  • Biggest five-year swings in Times Interest Earned: plummeted 9301.69% in 2022 and later soared 903.61% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Times Interest Earned stood at $0.86 in 2020, then surged by 54.9% to $1.33 in 2021, then plummeted by 211.23% to -$1.48 in 2022, then skyrocketed by 69.15% to -$0.46 in 2023, then grew by 7.39% to -$0.42 in 2024.
  • The last three reported values for Times Interest Earned were -$0.42 (Q4 2024), -$11.78 (Q3 2024), and $0.18 (Q2 2024) per Business Quant data.